Industries > Pharma > Global Cancer Immunotherapy Market Forecast 2019-2029

Global Cancer Immunotherapy Market Forecast 2019-2029

Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Hospitals, Cancer Research Centres, Clinics

PUBLISHED: 21 January 2019
PAGES: 194
PRODUCT CODE: PHA0351

Clear
WOOCS 2.2.1

The world cancer immunotherapy market is expected to grow at a CAGR of 11.4% in the second half of the forecast period. The market reached $63bn in 2018, dominated by the monoclonal antibody segment which held 66% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 194-page report you will receive 110 tables and 93 figures– all unavailable elsewhere.

The 194-page report provides clear detailed insight into the global cancer-treating drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global cancer immunotherapy market forecasts from 2019-2029

• This report also breaks down the revenue forecast for the global cancer immunotherapy market by Technology:
• Monoclonal Antibodies
• Cytokines & immunomodulators
• Others (Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy)

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.

• This report also breaks down the revenue forecast for the global cancer immunotherapy market by Application:
• Lung Cancer
• Breast Cancer
• Colorectal cancer
• Melanoma Cancer
• Prostate Cancer
• Head & Neck Cancer,
• Others (Renal Cell Carcinoma, Cervical, Gastric, Lymphoma)

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.

• This report also breaks down the revenue forecast for the world cancer immunotherapy market by End-User:
• Hospitals
• Cancer Research Centers
• Clinics

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and ROW.

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: The UK, Germany, France, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• Rest of World: Middle East, Africa, Other Countries

Each regional market is further broken down by technology, application and end-user.

• This report discusses trends in the industry and assesses drivers and restraints, as well as opportunities and threats. It also includes porters’ five force analysis; threat of new entrants, power of suppliers, power of buyers, rivalry among competitors and threat of substituents.

• Our study discusses the selected leading companies that are the major players in the cancer immunotherapy market:
• Adaxic Inc
• AstraZeneca
• Bayer
• Bristol-Myers Squibb (BMS)
• Eli Lilly and Co.
• Medtronic Plc
• Merck & Co., Inc. (Merck)
• Novartis
• Pfizer
• Roche

Global Cancer Immunotherapy Market Forecast 2019-2029

The report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments.

Visiongain’s study is intended for anyone requiring commercial analyses for the global cancer Immunotherapy market. You find data, trends and predictions.

Buy our report today Global Cancer Immunotherapy Market Forecast 2019-2029: Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Hospitals, Cancer Research Centers, Clinics.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Cancer Immunotherapy Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Cancer Immunotherapy Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories